ADEVs enriched in miR-133b were shown to decrease the expression of connective tissue growth factor (CTGF), reduce glial scar wall, and induce neurite growth, thereby promoting neural recovery after stroke [191, 203]. Here, CCN2 is linked to stroke disorder.